TELMIKIND-LN

About

TELMIKIND-LN is a combination medication containing Telmisartan, an angiotensin II receptor blocker (ARB), and Lercanidipine, a dihydropyridine calcium channel blocker (CCB). Telmisartan works by selectively blocking the binding of angiotensin II to its receptors in vascular smooth muscle, leading to vasodilation and a reduction in blood pressure. Lercanidipine complements this action by inhibiting the influx of calcium ions into vascular smooth muscle cells, causing peripheral arterial vasodilation and further lowering blood pressure. This dual mechanism of action provides a comprehensive approach to managing essential hypertension, particularly in patients whose blood pressure is not adequately controlled by monotherapy with either component.

The synergistic effect of Telmisartan and Lercanidipine helps achieve more effective and sustained blood pressure control, reducing the risk of cardiovascular events such as stroke and myocardial infarction. The combination is often preferred for its improved efficacy and potentially better tolerability profile compared to higher doses of individual agents. It is a valuable option for patients requiring robust antihypertensive treatment to reach their target blood pressure goals.

Uses

• Treatment of essential hypertension in adults.
• Management of high blood pressure when monotherapy is insufficient.
• To reduce the risk of cardiovascular morbidity and mortality.
• For patients requiring combination therapy for blood pressure control.

Directions For Use

Take one tablet orally once daily, with or without food, as prescribed by your doctor. Swallow the tablet whole with water.

Benefits

• Provides effective and sustained blood pressure reduction.
• Offers a dual mechanism of action for comprehensive control.
• May reduce the risk of major cardiovascular events.
• Potentially improves patient compliance with once-daily dosing.
• Often better tolerated than high doses of single agents.
• Suitable for patients with uncontrolled hypertension on monotherapy.

Side Effects

• Dizziness
• Headache
• Peripheral edema
• Fatigue
• Flushing
• Nausea
• Abdominal pain
• Palpitations
• Hypotension
• Cough
• Hyperkalemia
• Muscle cramps

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can enhance the blood pressure-lowering effect and increase dizziness.
• Pregnancy - Contraindicated during the second and third trimesters due to potential fetal harm; consult a doctor if pregnant or planning pregnancy.
• Breastfeeding - Not recommended as components may pass into breast milk, potentially affecting the infant.
• Liver - Use with caution in patients with mild to moderate hepatic impairment; severe impairment may require dose adjustment or contraindication.
• Kidney - Use with caution in patients with renal impairment; regular monitoring of kidney function, including serum creatinine and potassium, is advised.
• Lung - Generally considered safe for use in patients with lung conditions; no specific pulmonary contraindications.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.